{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:42:26Z","timestamp":1791258146125,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18411965100"],"award-info":[{"award-number":["18411965100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000907"],"award-info":[{"award-number":["82000907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171078,81870670"],"award-info":[{"award-number":["82171078,81870670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.oret.2023.10.021","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T21:14:14Z","timestamp":1698959654000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Shixue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9384-5557","authenticated-orcid":false,"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4288-9736","authenticated-orcid":false,"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2023.10.021_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma: a review","volume":"4","author":"Pulido","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2023.10.021_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.survophthal.2020.02.001","article-title":"Eye involvement in primary central nervous system lymphoma","volume":"65","author":"Farrall","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.021_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.649789","article-title":"Relapsed primary central nervous system lymphoma: current advances","volume":"11","author":"Tao","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.oret.2023.10.021_bib4","first-page":"397","article-title":"Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma","volume":"41","author":"Zhuang","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oret.2023.10.021_bib5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/hon.3044","article-title":"Isolated intraocular relapses of primary cerebral lymphomas: an LOC network study","volume":"40","author":"Younan","year":"2022","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.oret.2023.10.021_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ajh.26199","article-title":"Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: an LOC network study","volume":"96","author":"Lam","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.oret.2023.10.021_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/bjh.17451","article-title":"Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience","volume":"194","author":"Habot-Wilner","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.oret.2023.10.021_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jamaophthalmol.2014.4755","article-title":"Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study","volume":"133","author":"Riemens","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.021_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.5301\/ejo.5000488","article-title":"Evaluation of cytologic specimens obtained during experimental vitreous biopsy using B-cell lymphoma line","volume":"24","author":"Jiang","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.021_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/neuonc\/nov253","article-title":"Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma","volume":"18","author":"Cheah","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.oret.2023.10.021_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bjh.14848","article-title":"Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma","volume":"179","author":"Kaburaki","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.oret.2023.10.021_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10428194.2013.819576","article-title":"Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone","volume":"55","author":"Teckie","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oret.2023.10.021_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/annonc\/mdm340","article-title":"Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report","volume":"18","author":"Grimm","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.oret.2023.10.021_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/OPTH.S159014","article-title":"Primary vitreoretinal lymphoma: prevalence, impact, and management challenges","volume":"13","author":"Venkatesh","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.021_bib15","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/IAE.0000000000003241","article-title":"Clinical features, diagnostic significance, and prognosis of vitreoretinal lymphoma in young patients","volume":"41","author":"Liu","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.10.021_bib16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.oret.2023.10.021_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101053","article-title":"Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches","volume":"90","author":"Takase","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2023.10.021_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40942-021-00346-0","article-title":"Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma","volume":"7","author":"Anthony","year":"2021","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2023.10.021_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","article-title":"Consensus recommendations for the diagnosis of vitreoretinal lymphoma","volume":"29","author":"Carbonell","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2023.10.021_bib20","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/bjophthalmol-2018-313491","article-title":"Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze","volume":"103","author":"Marchese","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.021_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/IAE.0000000000002819","article-title":"Spectral domain optical coherence tomography features of vitreoretinal lymphoma in 55 Eyes","volume":"41","author":"Yang","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.10.021_bib22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00417-016-3395-x","article-title":"Optical coherence tomography manifestations of primary vitreoretinal lymphoma","volume":"254","author":"Saito","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.021_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/09273948.2012.752507","article-title":"Vitreoretinal lymphoma versus uveitis: cytokine profile and correlations","volume":"22","author":"Caraballo","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2023.10.021_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2020.12.035","article-title":"The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma","volume":"515","author":"Chen","year":"2021","journal-title":"Clin Chim Acta"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023005729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023005729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:13:10Z","timestamp":1729123990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653023005729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2468653023005729"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2023.10.021","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2023.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}